I wonder if the problems related to Anbang, one of Mincheng Bank's major shareholders, might adversely affect Minsheng Bank's ability or willingness to continue to prop up CDU?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%